vs
CATALYST PHARMACEUTICALS, INC.（CPRX）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
CATALYST PHARMACEUTICALS, INC.的季度营收约是Ranger Energy Services, Inc.的1.1倍（$152.6M vs $142.2M），CATALYST PHARMACEUTICALS, INC.净利率更高（34.5% vs 2.3%，领先32.3%），CATALYST PHARMACEUTICALS, INC.同比增速更快（7.6% vs -0.6%），CATALYST PHARMACEUTICALS, INC.自由现金流更多（$44.9M vs $17.1M），过去两年CATALYST PHARMACEUTICALS, INC.的营收复合增速更高（24.5% vs 1.9%）
Catalyst Pharmaceuticals是一家总部位于美国佛罗里达州科勒尔盖布尔斯的生物制药企业，专注于罕见病药物研发。核心产品包括用于治疗兰伯特-伊顿肌无力综合征（LEMS）的氨吡啶磷酸盐，商品名为Firdapse。该药物2018年11月获FDA批准，除原有成人适应症外，还可用于6岁及以上的LEMS儿童患者。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
CPRX vs RNGR — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $152.6M | $142.2M |
| 净利润 | $52.7M | $3.2M |
| 毛利率 | 82.9% | — |
| 营业利润率 | 40.5% | 2.3% |
| 净利率 | 34.5% | 2.3% |
| 营收同比 | 7.6% | -0.6% |
| 净利润同比 | -5.8% | -44.8% |
| 每股收益（稀释后） | $0.40 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $152.6M | $142.2M | ||
| Q3 25 | $148.4M | $128.9M | ||
| Q2 25 | $146.6M | $140.6M | ||
| Q1 25 | $141.4M | $135.2M | ||
| Q4 24 | $141.8M | $143.1M | ||
| Q3 24 | $128.7M | $153.0M | ||
| Q2 24 | $122.7M | $138.1M | ||
| Q1 24 | $98.5M | $136.9M |
| Q4 25 | $52.7M | $3.2M | ||
| Q3 25 | $52.8M | $1.2M | ||
| Q2 25 | $52.1M | $7.3M | ||
| Q1 25 | $56.7M | $600.0K | ||
| Q4 24 | $55.9M | $5.8M | ||
| Q3 24 | $43.9M | $8.7M | ||
| Q2 24 | $40.8M | $4.7M | ||
| Q1 24 | $23.3M | $-800.0K |
| Q4 25 | 82.9% | — | ||
| Q3 25 | 84.7% | — | ||
| Q2 25 | 85.9% | — | ||
| Q1 25 | 87.3% | — | ||
| Q4 24 | 84.7% | — | ||
| Q3 24 | 85.0% | — | ||
| Q2 24 | 87.4% | — | ||
| Q1 24 | 87.3% | — |
| Q4 25 | 40.5% | 2.3% | ||
| Q3 25 | 44.7% | 2.0% | ||
| Q2 25 | 45.2% | 6.1% | ||
| Q1 25 | 44.8% | 0.7% | ||
| Q4 24 | 44.3% | 6.2% | ||
| Q3 24 | 39.6% | 8.4% | ||
| Q2 24 | 44.2% | 5.3% | ||
| Q1 24 | 27.5% | -0.4% |
| Q4 25 | 34.5% | 2.3% | ||
| Q3 25 | 35.6% | 0.9% | ||
| Q2 25 | 35.6% | 5.2% | ||
| Q1 25 | 40.1% | 0.4% | ||
| Q4 24 | 39.4% | 4.1% | ||
| Q3 24 | 34.1% | 5.7% | ||
| Q2 24 | 33.2% | 3.4% | ||
| Q1 24 | 23.6% | -0.6% |
| Q4 25 | $0.40 | $0.14 | ||
| Q3 25 | $0.42 | $0.05 | ||
| Q2 25 | $0.41 | $0.32 | ||
| Q1 25 | $0.45 | $0.03 | ||
| Q4 24 | $0.44 | $0.24 | ||
| Q3 24 | $0.35 | $0.39 | ||
| Q2 24 | $0.33 | $0.21 | ||
| Q1 24 | $0.19 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $709.2M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $954.3M | $300.1M |
| 总资产 | $1.1B | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $709.2M | $10.3M | ||
| Q3 25 | $689.9M | $45.2M | ||
| Q2 25 | $652.8M | $48.9M | ||
| Q1 25 | $580.7M | $40.3M | ||
| Q4 24 | $517.6M | $40.9M | ||
| Q3 24 | $442.3M | $14.8M | ||
| Q2 24 | $375.7M | $8.7M | ||
| Q1 24 | $310.4M | $11.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $954.3M | $300.1M | ||
| Q3 25 | $920.2M | $270.0M | ||
| Q2 25 | $856.0M | $276.9M | ||
| Q1 25 | $794.3M | $272.6M | ||
| Q4 24 | $727.6M | $273.8M | ||
| Q3 24 | $660.9M | $267.6M | ||
| Q2 24 | $608.7M | $260.5M | ||
| Q1 24 | $561.4M | $261.7M |
| Q4 25 | $1.1B | $419.3M | ||
| Q3 25 | $1.1B | $372.8M | ||
| Q2 25 | $971.9M | $381.7M | ||
| Q1 25 | $908.9M | $376.5M | ||
| Q4 24 | $851.4M | $381.6M | ||
| Q3 24 | $772.0M | $373.9M | ||
| Q2 24 | $706.4M | $359.6M | ||
| Q1 24 | $646.7M | $355.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.9M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $44.9M | $17.1M |
| 自由现金流率自由现金流/营收 | 29.4% | 12.0% |
| 资本支出强度资本支出/营收 | 0.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.85× | 7.53× |
| 过去12个月自由现金流最近4个季度 | — | $42.9M |
8季度趋势，按日历期对齐
| Q4 25 | $44.9M | $24.1M | ||
| Q3 25 | $32.4M | $13.6M | ||
| Q2 25 | $71.3M | $20.7M | ||
| Q1 25 | $60.0M | $10.6M | ||
| Q4 24 | $70.9M | $32.7M | ||
| Q3 24 | $72.9M | $17.7M | ||
| Q2 24 | $64.1M | $22.1M | ||
| Q1 24 | $31.9M | $12.0M |
| Q4 25 | $44.9M | $17.1M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | $71.3M | $14.4M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | $70.8M | $27.3M | ||
| Q3 24 | $72.6M | $10.8M | ||
| Q2 24 | $64.1M | $6.8M | ||
| Q1 24 | $31.7M | $5.5M |
| Q4 25 | 29.4% | 12.0% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | 48.6% | 10.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 49.9% | 19.1% | ||
| Q3 24 | 56.4% | 7.1% | ||
| Q2 24 | 52.3% | 4.9% | ||
| Q1 24 | 32.2% | 4.0% |
| Q4 25 | 0.0% | 4.9% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 4.5% | ||
| Q1 25 | 0.0% | 5.3% | ||
| Q4 24 | 0.1% | 3.8% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.0% | 11.1% | ||
| Q1 24 | 0.2% | 4.7% |
| Q4 25 | 0.85× | 7.53× | ||
| Q3 25 | 0.61× | 11.33× | ||
| Q2 25 | 1.37× | 2.84× | ||
| Q1 25 | 1.06× | 17.67× | ||
| Q4 24 | 1.27× | 5.64× | ||
| Q3 24 | 1.66× | 2.03× | ||
| Q2 24 | 1.57× | 4.70× | ||
| Q1 24 | 1.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRX
| Firdapse | $97.6M | 64% |
| Agamree | $35.3M | 23% |
| Fycompa | $19.6M | 13% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
